Skip to main content
Polyrizon Ltd. logo

Polyrizon Ltd. — Investor Relations & Filings

Ticker · PLRZ ISIN · IL0011814113 US Manufacturing
Filings indexed 148 across all filing types
Latest filing 2025-09-17 Foreign Filer Report
Country US United States of America
Listing US PLRZ

About Polyrizon Ltd.

https://polyrizon-biotech.com/

Polyrizon Ltd. is a clinical-stage biotechnology company focused on the development and commercialization of innovative intranasal products. The company's core technology is based on proprietary hydrogels delivered as nasal sprays. Polyrizon is advancing two primary platforms: Capture & Contain™ (C&C), which creates a protective bioadhesive gel barrier in the nasal cavity to block airborne pathogens and allergens, and Trap & Target™ (T&T), a system designed for the targeted intranasal delivery of therapeutic drugs. The company's pipeline includes candidates for preventative treatments, such as allergy blockers, and drug delivery systems with potential applications for the central nervous system (CNS).

Recent filings

Filing Released Lang Actions
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-09-17 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-09-04 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-08-14 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-07-31 English
REGISTRATION STATEMENT
Registration Form
2025-07-24 English
REPORT OF FOREIGN PRIVATE ISSUER
Foreign Filer Report
2025-07-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.